文献速递神经肿瘤

荧光内镜联合二次窗吲哚菁绿用于恶性脑肿瘤手术切除

Fluorescence Endoscopy with Second Window Indocyanine Green for Surgical Resection of Malignant Brain Tumors.
PubMed 文献 · World Neurosurg · 2025-03-06

本研究纳入22例恶性脑肿瘤患者,术前24小时内静脉给予吲哚菁绿250 mg,在内镜引导下手术,以术后24小时内增强头颅磁共振和病理为参考验证荧光内镜联合二次窗吲哚菁绿(FESWICG)技术的灵敏度与特异度,并评估手术前后卡氏功能状态评分。

要点

  • 22例中术中肿瘤荧光强20例、弱2例,术后增强影像示18例(81.82%)完全切除。
  • 以病理为参考,FESWICG检测恶性脑肿瘤的灵敏度91.42%、特异度41.38%、阳性预测值65.31%、阴性预测值80%。
  • 卡氏功能状态评分中位数术前85分、术后3个月随访93分。

核心结论

  • 二次窗吲哚菁绿显著增强了恶性脑肿瘤的术中可视化,尤其有助于区分肿瘤与正常脑组织。
  • 其在切缘检测方面的效用有前景,与完整内镜系统联合使用可大幅提升视觉清晰度和手术整体效果。
  • 但吲哚菁绿仍是一种低特异度技术。

研究设计与样本

  • 研究纳入22例接受恶性脑肿瘤切除术的患者。
  • 术前24小时内静脉给予吲哚菁绿250 mg,所有操作在内镜引导下完成。
  • 采集包括切缘在内的标本送组织病理学分析,以术后24小时内增强头颅磁共振和病理为参考验证FESWICG的灵敏度与特异度。
  • 采用卡氏功能状态评分评估手术前后整体功能状态。

主要发现

  • 肿瘤诊断:胶质瘤14例、室管膜瘤1例、转移瘤5例、淋巴瘤1例、脉络丛乳头状瘤1例。
  • 术中肿瘤荧光强20例、弱2例;术后增强影像示18例(81.82%)完全切除。
  • 共采集64份肿瘤标本,其中42份取自肿瘤切缘。
  • 以病理为参考,FESWICG检测恶性脑肿瘤的灵敏度91.42%、特异度41.38%、阳性预测值65.31%、阴性预测值80%。
  • 卡氏功能状态评分中位数术前85分、术后3个月随访93分。

关键数值与推荐

  • FESWICG检测恶性脑肿瘤以病理为参考的灵敏度为91.42%、特异度为41.38%、阳性预测值为65.31%、阴性预测值为80%。
  • 术后增强影像示完全切除18例(81.82%)。
  • 卡氏功能状态评分中位数术前85分、术后3个月随访93分。

临床怎么用

  • 原文结论认为二次窗吲哚菁绿显著增强恶性脑肿瘤术中可视化,尤其有助于区分肿瘤与正常脑组织。
  • 原文结论认为其切缘检测效用有前景,与完整内镜系统联合使用可大幅提升视觉清晰度和手术整体效果。
  • 原文指出吲哚菁绿仍是一种低特异度技术。

局限性

  • 原文指出吲哚菁绿仍是一种低特异度技术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to validate the clinical feasibility, safety, and effectiveness of using the fluorescence endoscopy with second window indocyanine green (FESWICG) technique for resection of malignant brain tumors. METHODS: Twenty-two patients undergoing surgery for malignant brain tumor resection were examined. Intravenous ICG (250 mg) was administered within 24 hours prior to surgery. All procedures were performed under endoscopic guidance. The fluorescence intensity of the tumors was monitored using fluorescence mode endoscopy. Specimens including resection margins were harvested and submitted for histopathological analysis. The sensitivity and specificity of FESWICG were validated using contrast-enhanced cranial magnetic resonance imaging performed within 24 hours of surgery and histopathology. The Karnofsky performance scale was used to assess overall functional status before and after surgery. RESULTS: The tumor diagnoses were as follows: glioma (n = 14), ependymoma (n = 1), metastasis (n = 5), lymphoma (n = 1), and choroid plexus papilloma (n = 1). Intraoperative tumor fluorescence was strong in 20 patients and weak in 2. Postoperative contrast-enhanced imaging revealed complete tumor resection in 18 patients (81.82%). Sixty-four tumor specimens were collected, including 42 obtained from tumor margins. Using histopathology as the reference, the sensitivity, specificity, positive predictive value, and negative predictive value of FESWICG for detection of malignant brain tumors were 91.42%, 41.38%, 65.31%, and 80%, respectively. The median Karnofsky performance scale score was 85 before surgery and 93 at the 3-month follow-up. CONCLUSIONS: SWICG notably enhanced intraoperative visualization of malignant brain tumors, particularly the delineation between tumor and normal brain. Its utility for margin detection is promising. When utilized in conjunction with a full endoscopic system, the visual acuity and overall effectiveness of surgical procedures can be substantially enhanced. However, ICG remains a low-specificity technique.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Xu Y, Zhang T, Li Z, et al. Fluorescence Endoscopy with Second Window Indocyanine Green for Surgical Resection of Malignant Brain Tumors. World Neurosurg. 2025. PMID: 39955047. doi:10.1016/j.wneu.2025.123766

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。